ペプチドリームの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/05/16 | 3,075 | 3,115 | 3,025 | 3,070 | +30 | +1% | 1,235,600 |
| 2017/05/15 | 2,855 | 3,050 | 2,850 | 3,040 | +10 | +0.3% | 1,987,200 |
| 2017/05/12 | 3,035 | 3,070 | 3,005 | 3,030 | -50 | -1.6% | 948,400 |
| 2017/05/11 | 3,095 | 3,165 | 3,065 | 3,080 | -30 | -1% | 1,287,400 |
| 2017/05/10 | 3,135 | 3,145 | 3,085 | 3,110 | +20 | +0.6% | 1,273,400 |
| 2017/05/09 | 3,145 | 3,200 | 3,080 | 3,090 | -10 | -0.3% | 2,262,000 |
| 2017/05/08 | 3,125 | 3,160 | 3,060 | 3,100 | +215 | +7.5% | 4,744,200 |
| 2017/05/02 | 3,070 | 3,075 | 2,765 | 2,885 | -180 | -5.9% | 8,754,200 |
| 2017/05/01 | 3,155 | 3,160 | 2,930 | 3,065 | -270 | -8.1% | 7,065,800 |
| 2017/04/28 | 3,345 | 3,350 | 3,290 | 3,335 | -30 | -0.9% | 1,498,800 |
| 2017/04/27 | 3,380 | 3,400 | 3,340 | 3,365 | ±0 | ±0% | 856,800 |
| 2017/04/26 | 3,350 | 3,375 | 3,310 | 3,365 | +35 | +1.1% | 1,075,200 |
| 2017/04/25 | 3,400 | 3,445 | 3,310 | 3,330 | -20 | -0.6% | 2,137,200 |
| 2017/04/24 | 3,345 | 3,375 | 3,300 | 3,350 | ±0 | ±0% | 1,036,400 |
| 2017/04/21 | 3,370 | 3,425 | 3,335 | 3,350 | -35 | -1% | 1,102,400 |
| 2017/04/20 | 3,360 | 3,470 | 3,290 | 3,385 | +40 | +1.2% | 2,379,000 |
| 2017/04/19 | 3,335 | 3,415 | 3,330 | 3,345 | -25 | -0.7% | 1,659,600 |
| 2017/04/18 | 3,455 | 3,455 | 3,315 | 3,370 | -55 | -1.6% | 2,616,800 |
| 2017/04/17 | 3,235 | 3,430 | 3,220 | 3,425 | +230 | +7.2% | 3,723,800 |
| 2017/04/14 | 3,200 | 3,265 | 3,150 | 3,195 | -35 | -1.1% | 3,309,800 |
| 2017/04/13 | 2,965 | 3,250 | 2,960 | 3,230 | +260 | +8.8% | 4,458,600 |
| 2017/04/12 | 2,950 | 3,020 | 2,930 | 2,970 | -75 | -2.5% | 2,991,000 |
| 2017/04/11 | 3,100 | 3,135 | 2,980 | 3,045 | -80 | -2.6% | 7,870,600 |
| 2017/04/10 | 3,075 | 3,125 | 3,060 | 3,125 | +500 | +19% | 5,420,200 |
| 2017/04/07 | 2,625 | 2,655 | 2,585 | 2,625 | +25 | +1% | 1,141,200 |
| 2017/04/06 | 2,605 | 2,610 | 2,550 | 2,600 | -15 | -0.6% | 1,139,800 |
| 2017/04/05 | 2,605 | 2,625 | 2,580 | 2,615 | +15 | +0.6% | 996,800 |
| 2017/04/04 | 2,640 | 2,650 | 2,560 | 2,600 | -60 | -2.3% | 1,237,400 |
| 2017/04/03 | 2,670 | 2,695 | 2,635 | 2,660 | +35 | +1.3% | 839,200 |
| 2017/03/31 | 2,655 | 2,665 | 2,625 | 2,625 | -15 | -0.6% | 752,200 |
| 2017/03/30 | 2,735 | 2,745 | 2,625 | 2,640 | -105 | -3.8% | 1,228,000 |
| 2017/03/29 | 2,750 | 2,780 | 2,735 | 2,745 | +25 | +0.9% | 919,800 |
| 2017/03/28 | 2,690 | 2,725 | 2,665 | 2,720 | +80 | +3% | 993,600 |
| 2017/03/27 | 2,655 | 2,700 | 2,635 | 2,640 | -5 | -0.2% | 716,600 |
| 2017/03/24 | 2,645 | 2,665 | 2,625 | 2,645 | ±0 | ±0% | 551,200 |
| 2017/03/23 | 2,645 | 2,650 | 2,610 | 2,645 | -10 | -0.4% | 791,200 |
| 2017/03/22 | 2,635 | 2,675 | 2,630 | 2,655 | -25 | -0.9% | 573,000 |
| 2017/03/21 | 2,670 | 2,705 | 2,670 | 2,680 | -15 | -0.6% | 557,000 |
| 2017/03/17 | 2,740 | 2,745 | 2,670 | 2,695 | -55 | -2% | 830,800 |
| 2017/03/16 | 2,710 | 2,760 | 2,705 | 2,750 | +40 | +1.5% | 604,800 |
| 2017/03/15 | 2,785 | 2,800 | 2,665 | 2,710 | -95 | -3.4% | 1,468,800 |
| 2017/03/14 | 2,840 | 2,840 | 2,785 | 2,805 | -45 | -1.6% | 947,200 |
| 2017/03/13 | 2,885 | 2,905 | 2,845 | 2,850 | -30 | -1% | 991,800 |
| 2017/03/10 | 2,835 | 2,885 | 2,830 | 2,880 | +65 | +2.3% | 1,032,000 |
| 2017/03/09 | 2,785 | 2,825 | 2,780 | 2,815 | +35 | +1.3% | 906,200 |
| 2017/03/08 | 2,755 | 2,790 | 2,750 | 2,780 | +5 | +0.2% | 939,000 |
| 2017/03/07 | 2,780 | 2,785 | 2,740 | 2,775 | -10 | -0.4% | 802,600 |
| 2017/03/06 | 2,765 | 2,805 | 2,765 | 2,785 | +20 | +0.7% | 928,000 |
| 2017/03/03 | 2,750 | 2,790 | 2,750 | 2,765 | +30 | +1.1% | 1,052,000 |
| 2017/03/02 | 2,775 | 2,775 | 2,715 | 2,735 | -15 | -0.5% | 1,121,000 |
1951～
2000
件表示中 / 2911件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ペプチド | 184,600円 | +5.0% | +1.5% | 0.00% | 15.85倍 | 4.22倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 住友ファーマ | 91,400円 | +26.8% | - | 0.00% | 15.39倍 | 3.18倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 368,800円 | +20.9% | +87.3% | 3.69% | 8.24倍 | 0.95倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 328,400円 | +8.0% | -15.3% | 3.78% | 9.22倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 197,000円 | +4.0% | +25.4% | 2.69% | 8.62倍 | 1.13倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
市場注目の銘柄
チャート関連のコラム
